AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
287 hedge funds and large institutions have $2.85B invested in Amedisys in 2024 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 93 increasing their positions, 104 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% less capital invested
Capital invested by funds: $2.86B → $2.85B (-$5.79M)
11% less repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 104
82% less call options, than puts
Call options by funds: $17.1M | Put options by funds: $94.3M
Holders
287
Holding in Top 10
13
Calls
$17.1M
Puts
$94.3M
Top Buyers
| 1 | +$96.9M | |
| 2 | +$27.9M | |
| 3 | +$19.4M | |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
+$18.5M |
| 5 |
SGCM
Sand Grove Capital Management
London,
United Kingdom
|
+$17.5M |
Top Sellers
| 1 | -$32.3M | |
| 2 | -$29.6M | |
| 3 | -$19.5M | |
| 4 |
MAM
Melqart Asset Management
London,
United Kingdom
|
-$18.9M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
-$18.3M |